WEST CHESTER, Pa., November 10, 2020 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced positive topline results from its Phase 2 CARE-1 clinical study of…
Read More
Second Russian coronavirus vaccine candidate finishes Phase II human trials: report
President Trump hints at coronavirus vaccine by October CDC tells states to prepare by November; Fox News medical correspondent Dr. Marc Siegel weighs in. Researchers in Russia finished Tuesday the early-stage human trials of a second COVID-19 vaccine candidate, according to a report….
Read More
AI-assisted mammography must move into a critical new phase of prospective clinical evaluation
To impact and improve patient care, the study of artificial intelligence (AI) tools to support screening mammography must now shift from simulated research trials to robust clinical evaluations, according to Constance Lehman, MD, Ph.D., director of Breast Imaging at Massachusetts…
Read More
Moderna’s coronavirus vaccine has moved to second phase of testing
The Food and Drug administration (FDA) has given approval to biotech company Moderna to begin the next phase of testing on its coronavirus vaccine candidate, the company announced Thursday (May 7). There are dozens of vaccine candidates worldwide that are…
Read More